BAYER A.G. (BAYZF)
Clinical trial NCT06632483 updates: 1. completion date: 2026-04-30 → 2026-06-30 2. primary completion date: 2026-04-30 → 2026-06-30
Clinical trial NCT06632483 updates: 1. completion date: 2026-04-30 → 2026-06-30 2. primary completion date: 2026-04-30 → 2026-06-30
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical